ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BYOT Byotrol Plc

0.10
0.00 (0.00%)
27 Jan 2025 - Closed
Delayed by 15 minutes
Byotrol Investors - BYOT

Byotrol Investors - BYOT

Share Name Share Symbol Market Stock Type
Byotrol Plc BYOT London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.10 00:00:00
Open Price Low Price High Price Close Price Previous Close
0.10 0.10
more quote information »
Industry Sector
CHEMICALS

Top Investor Posts

Top Posts
Posted at 05/12/2024 10:01 by loafofbread
Oh well.....

Due to ongoing negotiations relating to existing IP contracts, we are going to postpone the publishing of our Interim Results on 5th December along with our IMC Investor presentation on Wednesday 11th
December. Once negotiations have concluded we will announce our revised timings, and in any event we intend to provide an update by the end of this month. In line with this, we will also delay the closing date of the next Asset Match auction.
Posted at 27/11/2024 13:24 by loafofbread
Looking forward to the update.

Very pleased that they are doing exactly as they said they would with regard to keeping investors informed.
Posted at 25/11/2024 15:49 by football
Their have been reading your post loaf


25 November 2024



Dear Shareholder

Byotrol Limited’s Interim Results for the six months to 30 September 2024, Trading Update and Investor Presentation via
Investor Meet Company

This Notice is to advise you that Byotrol Limited's unaudited Interim Results for the six months to 30 September 2024 along with a Trading Update will be released on Thursday 5th December 2024. These will be published on the Company’s website at hxxps://www.byotrolplc.com and on the secondary trading platform Asset Match www.assetmatch.com

Investor Presentation via Investor Meet Company

Chris Sedwell and Ashley Head will provide a live presentation relating to the Interim Results and Trading Update via Investor Meet Company on 11 Dec 2024, 10:00 GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 10 Dec 2024, 09:00 GMT, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet BYOTROL - Private via:

hxxps://www.investormeetcompany.com/byotrol-private/register-investor

Investors who already follow BYOTROL - Private on the Investor Meet Company platform will automatically be invited.

Thank you for your continuing support.

Yours sincerely



Ashley Head Chairman
Posted at 11/9/2024 09:58 by 1gw
Byotrol AGM about to start, broadcast via Investor Meet Company.
Posted at 26/4/2024 07:40 by loafofbread
Interesting to see if Byotrol follow the lead of other companies going down the delisting route?

MOLECULAR ENERGIES PLC
("Molecular" or the "Company")

Last Day of Dealings on AIM
Post Cancellation Shareholder Communications

Molecular Energies plc (AIM: MEN), provides an update on the matters described in the circular to shareholders dated 28 March 2024 and further information on shareholder communication following cancellation of the admission of the Company's ordinary shares to trading on AIM ("Cancellation").

Cancellation of admission to AIM

Cancellation will take place at 7.00 a.m. on 29 April 2024. The final day of dealings in the Company's shares on AIM is today, 26 April 2024.

Website

The current format of the website of the Company will be re-structured and will be live with effect from 1 May 2024.

The website will provide up to date information with regard to all material developments of the Company and members of its group. Whilst some sections of the current website will no longer be applicable, in order to promote transparency as a private company new features will be added with the aim of strengthening the connection between the Company and its remaining shareholders.

Communication

Molecular recognises that as a private company, it is imperative to ensure that those who came on its journey are kept regularly informed.

Accordingly, Molecular will publish news of all material developments both on its website and via its social media accounts, which it will continue to maintain. A regular newsletter providing business updates will be issued with the first anticipated by 30 September 2024, by which date the Company anticipates that it will publish its annual accounts for the year ended 31 December 2023. The Company will maintain its shareholder communications email address - info@molecularenergiesplc.com - and investors wishing to receive these regular updates or enter into dialogue with the Company are encouraged to email that address requesting to sign up.

Dealing Arrangements

The Company's ordinary shares will be admitted to trading on the JP Jenkins securities matching platform from the 29 April 2024.

JP Jenkins provides a securities matching venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell shares on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

The indicative pricing for the ordinary Shares (ISIN: GB00BMT80K89), as well as the transaction history, will be available on the JP Jenkins website at (hxxps://jpjenkins.com/company/molecular-energies/).

The provision of the matched bargain facility will be kept under review by the Board and, in determining whether to continue to offer a matched bargain facility, the Company shall consider expected (and communicated) shareholder demand for such a facility as well as the composition of the Company's register of members and the costs to the Company and shareholders.
Posted at 07/4/2024 15:36 by loafofbread
Less than 2 years ago they thought 3.25p was a decent price.

35 times more than our current share price

Todays price is as artificial as you could get.

The second relates to the Convertible Bond. The Group issued a Convertible Bond for GBP1m in July 2022 to new and existing investors in the Company, including Board directors. The Loan Notes have a term of five years, are senior in ranking, unsecured and convertible at investors' option into ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 3.25 pence per Ordinary Share, representing a 30% premium to the mid-price of the Company's share price at close of business on 26 July 2022. The Loan Notes carry a coupon of 9% per annum, payable quarterly in arrears. Based on the issue size of GBP1,000,000, the Loan Notes would, if converted, represent approximately 30,769,230 Ordinary Shares, amounting to 6.8% of the current issued share capital of the Company. However, as the average Byotrol share price since the issue of the Convertible Bond has been below the 3.25p conversion price, these are currently classed as non-dilutive and do not feature in the Denominator calculation above.
Posted at 03/4/2024 08:14 by clocktower
The reason for so many leaving the market I suspect, is that directors have been allowed to get away with fleecing investors through their lifestyle and mining value away from small investors, and even when it can be seen that there is no regulations or accountability for their actions, the market turns a blind eye and allows investors to be defrauded and because the SFO doesn’t look at anything below around £50 million, so it’s become the casino of choice.

I do not think that applies in this case, it is just failure to sell in volume and poor margins for the company and resellers.


I said sometime ago, it needs new leadership and stakeholders now need to delist and remove the BOD and take control.
Posted at 01/11/2023 09:04 by loafofbread
Peel Hunt. Doom Loop. Says it all really!

Britain’s small and medium-sized companies are trapped in a “doom loop” that risks destroying a crucial part of the UK’s financial ecosystem, analysts have warned.

The pace of decline for listed companies outside the FTSE 100 and FTSE 250 is “relentless221;, according to a report published by Peel Hunt.

The investment bank highlighted a 10pc decline in the number of companies on the FTSE’s SmallCap index. This number has declined by 30pc over the last five years.

It said markets are being hit by a swirl of negative factors including low valuations, falling liquidity, investors withdrawing their funds and a lack of initial public offerings (IPOs).

Charles Hall, head of research at Peel Hunt, said: “The pace of decline is relentless and is likely to continue unless effective action is taken quickly.

“We are currently in a doom loop, where valuations are low, liquidity is reducing, investors are seeing withdrawals and there is little desire to IPO.”

He called on the Government to bring in reforms to make it more attractive for smaller companies to list in the UK and more lucrative for investors to hold shares in those companies.

He added: “It is still significantly more onerous to be listed in terms of costs, bureaucracy, regulations and distraction for management, in stark contrast to private markets, where leverage is typically materially higher, pricing is opaque and there are tax advantages.”
Posted at 23/8/2023 06:03 by football
Todays RNs Wednesday


Byotrol PLC Investor Presentation via Investor Meet Company
23/08/2023 7:00am
RNS Non-Regulatory

TIDMBYOT

Byotrol PLC

23 August 2023

RNS Reach

Byotrol plc

("Byotrol" or the "Company")

Investor Presentation via Investor Meet Company

Byotrol plc (AIM: BYOT), the specialist infection prevention and control company is pleased to announce that Vivan Pinto, CEO, David Traynor, Executive Director, and Chris Sedwell, CFO, will provide a live presentation relating to the Full Year Results via Investor Meet Company on 8th Sep 2023 at 11:00am BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet BYOTROL PLC via:



Investors who already follow BYOTROL PLC on the Investor Meet Company platform will automatically be invited.

For further information, visit www.byotrolplc.com , follow on twitter @byotrol, or contact
Posted at 26/7/2023 11:07 by 1gw
Secondly, byotrol’s approach to investors. I don’t think byotrol deliberately keeps investors in the dark. If you look at the IMC sessions there is a lot of data provided in the presentation packs and they appear to try to answer all investor questions. However, they do not appear to believe that they need to court retail investors by offering more than the regulation 2 sessions per year (full year results around September and interims around December, plus the AGM for those that can make it) or by putting out non-regulatory releases to update investors on implementation of plans. I think in the past this was a cost-benefit decision informed by a view that they wouldn’t need to go to the market for funds in the foreseeable future (remember “sustainably cashflow positive” from their broker). They were (apparently) caught out last year by the post-covid dip in product sales and the delay vs expectations in Actizone (and other IP) revenues and had to seek some funds to maintain growth spend, hence the convertibles issue.

They are hamstrung by NDA’s. Having talked to Solvay and seen the same sort of reticence there, I think that is genuine. However, they have repeatedly missed guidance on IP deal delivery, most notably with the profit warnings in FY22. Despite this they continue to be opaque about their forecasts. They have forecast returning to profit this year but there is very little context about the extent to which this (again) assumes delivery of new IP deals. They have put out expectations for FY23, FY24 and FY25 via finnCap, but appear to have missed product sales expectations for the first 6-month period (2H FY23) and have given no quantified sense of how their first big product launch (Anigene) has gone or why we have seen nothing of the expected move into Europe with it. That does little to build investor confidence and it’s perhaps not surprising that, other than little bounces around specific news items (EPA registration, seaweed patent) there has been no sustained recovery in the shareprice.

We are coming into the news period of the year, with full year results, AGM and interims. We have a new chairman (TF) and a relatively new CEO (VP). If retail investors want the company to change its approach, then this is the time of year they get a chance to make their views known. I would urge those that feel strongly about it to lobby chairman, CEO and CFO when they get the chance.

Your Recent History

Delayed Upgrade Clock